Evaluation of ubiquitin C-terminal hydrolase-L1 enzyme levels in patients with epilepsy

Yasak, Ibrahim Halil; Yilmaz, Mustafa; Gonen, Murat; Atescelik, Metin; Gurger, Mehtap; Ilhan, Nevin; Goktekin, Mehmet Cagri.
Arq. neuropsiquiatr ; 78(7): 424-429, July 2020. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1131727

Documentos relacionados

  1. Evaluation of ubiquitin C-terminal hydrolase-L1 enzyme levels in patients with epilepsy.
  2. Interictal interleukin-6 and tumor necrosis factor α levels are associated with seizure recurrence in adults with epilepsy.
  3. Correlation of MMP-9 and HMGB1 expression with the cognitive function in patients with epilepsy and factors affecting the prognosis.
  4. Elevated blood purine levels as a biomarker of seizures and epilepsy.
  5. Circulating glial fibrillary acidic protein and ubiquitin carboxy-terminal hydrolase-L1 as markers of neuronal damage in children with epileptic seizures.
  6. The diagnostic value of serum UCHL-1 and S100-B levels in differentiate epileptic seizures from psychogenic attacks.
  7. Ultra-Long-Term-EEG Monitoring (ULTEEM) Systems: Towards User-Friendly Out-of-Hospital Recordings of Electrical Brain Signals in Epilepsy.
  8. LC-MS/MS method for the differential diagnosis of treatable early onset inherited metabolic epilepsies.
  9. Accuracy of patient-reported spell duration: A comparative study.
  10. The clinical and genetic landscape of developmental and epileptic encephalopathies in Egyptian children.